Scarica l'app Stockscreener
4.06
3.57%
0.14
Precedente Chiudi:
$3.92
Aprire:
$3.87
Volume 24 ore:
78,226
Relative Volume:
0.34
Capitalizzazione di mercato:
$228.68M
Reddito:
$2.76M
Utile/perdita netta:
$-49.12M
Rapporto P/E:
-2.7067
EPS:
-1.5
Flusso di cassa netto:
$-46.21M
1 W Prestazione:
+6.01%
1M Prestazione:
+0.50%
6M Prestazione:
+59.22%
1 anno Prestazione:
-13.98%
Intervallo 1D:
$3.8516
$4.075
Intervallo di 1 settimana:
$3.76
$4.1199
Portata 52W:
$2.20
$5.424
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
Nome
Orchestra Biomed Holdings Inc
Settore
Industria
Telefono
646-343-9298
Indirizzo
150 UNION SQUARE DRIVE, NEW HOPE
Compare OBIO vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OBIO
Orchestra Biomed Holdings Inc
|
4.05 | 221.34M | 2.76M | -49.12M | -46.21M | -1.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
486.10 | 121.15B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
788.52 | 82.43B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
835.15 | 52.25B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
330.83 | 44.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
366.85 | 40.07B | 4.98B | 69.60M | 525.67M | 0.5198 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-10 | Iniziato | TD Cowen | Buy |
| 2025-08-20 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-03-20 | Iniziato | BTIG Research | Buy |
| 2025-01-02 | Iniziato | Barclays | Overweight |
| 2024-08-22 | Iniziato | H.C. Wainwright | Buy |
| 2024-07-25 | Iniziato | B. Riley Securities | Buy |
| 2024-01-19 | Iniziato | Jefferies | Buy |
| 2023-02-24 | Iniziato | Piper Sandler | Overweight |
| 2023-02-07 | Iniziato | Chardan Capital Markets | Buy |
Mostra tutto
Orchestra Biomed Holdings Inc Borsa (OBIO) Ultime notizie
Gains Report: Is Tuya Inc Depositary Receipt a play on infrastructure spending - baoquankhu1.vn
Will Orchestra BioMed Holdings Inc. benefit from geopolitical trendsJuly 2025 Decliners & Real-Time Volume Analysis Alerts - mfd.ru
Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences - GlobeNewswire
Orchestra BioMed (NASDAQ:OBIO) Trading 4.2% HigherHere's What Happened - MarketBeat
Orchestra BioMed Grants Inducement Stock Options to Nine New Employees - MyChesCo
Earnings Recap: Will MITTPRA stock hit new highs in YEARQuarterly Earnings Report & Expert Approved Trade Ideas - baoquankhu1.vn
Orchestra BioMed announces inducement grants - Medical Buyer
What is Orchestra BioMed Holdings Inc. s P E ratio telling usJuly 2025 Drop Watch & Low Risk Profit Maximizing Plans - mfd.ru
Orchestra BioMed Adopts 2026 Performance-Driven Executive Compensation Plan - TipRanks
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Orchestra BioMed Grants Stock Options to New Employees as Part of 2025 Inducement Plan - Quiver Quantitative
Does Orchestra BioMed Holdings Inc. outperform in volatile markets2025 Price Targets & Growth Focused Investment Plans - mfd.ru
Targets Report: How Orchestra BioMed Holdings Inc. stock performs after earningsJuly 2025 Outlook & AI Forecasted Stock Moves - mfd.ru
How sensitive is Orchestra BioMed Holdings Inc. to inflation2025 Trade Ideas & Fast Exit/Entry Strategy Plans - mfd.ru
MACD Signal: What is Orchestra BioMed Holdings Incs 5 year growth outlookEntry Point & Reliable Price Breakout Alerts - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Orchestra BioMed Holdings (OBIO), LENZ Therapeutics (LENZ) and Amgen (AMGN) - The Globe and Mail
Short Covering: Does Orchestra BioMed Holdings Inc outperform in volatile markets2025 Year in Review & Weekly Watchlist of Top Performers - baoquankhu1.vn
Guidance Update: Does Orchestra BioMed Holdings Inc stock benefit from AI growth2025 Winners & Losers & Long-Term Growth Portfolio Plans - baoquankhu1.vn
Risk Report: Is Rafael Holdings Inc affected by consumer sentimentShare Buyback & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) largest shareholders are retail investors with 41% ownership, institutions own 17% - Yahoo Finance
Aug Setups: What is Orchestra BioMed Holdings Inc. s 5 year growth outlookWeekly Trading Summary & Intraday High Probability Setup Alerts - baoquankhu1.vn
Orchestra BioMed Highlights AVIM Therapy’s Potential at CSI 2025 Meeting - MSN
AMH Equity Ltd Buys New Position in Orchestra BioMed Holdings, Inc. $OBIO - Defense World
Orchestra BioMed (NASDAQ:OBIO) versus Prima BioMed (NASDAQ:IMMP) Critical Analysis - Defense World
Retail Trends: Does PNTG have strong fundamentalsQuarterly Trade Summary & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Support Test: Is Orchestra BioMed Holdings Inc stock a contrarian buyQuarterly Performance Summary & Safe Entry Momentum Stock Tips - Bộ Nội Vụ
Retail Trends: Should value investors consider Orchestra BioMed Holdings Inc - baoquankhu1.vn
symbol__ Stock Quote Price and Forecast - CNN
Haemonetics (HAE) Acquisition of Vivasure Boosts Orchestra BioMed's Finances - GuruFocus
Orchestra BioMed Holdings, Inc. to Receive Proceeds from Vivasure Acquisition - TradingView
Early bet on vessel-closure patch could bring this firm $21M windfall - Stock Titan
Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics - Sahm
Assessing Orchestra BioMed Hldgs: Insights From 4 Financial Analysts - Benzinga
Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) market cap touched US$251m last week, benefiting both retail investors who own 41% as well as institutions - Sahm
Can Orchestra BioMed Holdings Inc. stock continue upward trendForecast Cut & Long-Term Growth Portfolio Plans - Улправда
Can Orchestra BioMed Holdings Inc. stock rebound after recent weakness2025 Historical Comparison & Weekly Watchlist of Top Performers - ulpravda.ru
Published on: 2026-01-09 01:26:31 - Улправда
Is Orchestra BioMed Holdings Inc. stock a dividend growth opportunityJuly 2025 Update & Daily Chart Pattern Signal Reports - ulpravda.ru
Is Orchestra BioMed Holdings Inc. stock a safe buy before earningsBreakout Watch & Daily Profit Focused Stock Screening - Улправда
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Orchestra BioMed (NASDAQ:OBIO) Shares Up 0.2% – Here’s Why - Defense World
TD Cowen Initiates Orchestra BioMed (OBIO), Cites High-Margin Potential in Lead Cardiovascular Programs - Insider Monkey
Orchestra BioMed to Highlight Advancements in Cardiac Therapy at HRS 2025 - MSN
Orchestra BioMed Grants New Hire Stock Options as Clinical Programs Advance - MSN
What drives Orchestra BioMed Holdings Inc stock priceEarnings Beat Highlights & Receive Monthly Expert Trading Blueprints - earlytimes.in
Orchestra BioMed Holdings, Inc.(NasdaqGM: OBIO) added to NASDAQ Biotechnology Index - marketscreener.com
Why Orchestra BioMed Holdings Inc. stock is in analyst buy zone2025 Top Decliners & Low Risk High Win Rate Stock Picks - Улправда
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q4 Loss, Lags Revenue Estimates - MSN
Orchestra Biomed Holdings Inc Azioni (OBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Orchestra Biomed Holdings Inc Azioni (OBIO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Aryeh Jason | Director |
Sep 19 '25 |
Buy |
2.45 |
1,000 |
2,450 |
108,482 |
| Fain Eric S | Director |
Aug 25 '25 |
Buy |
2.61 |
5,760 |
15,034 |
71,709 |
| Sherman Darren | See Remarks |
Aug 25 '25 |
Buy |
2.62 |
3,000 |
7,860 |
926,837 |
| Hochman David P | See Remarks |
Aug 21 '25 |
Buy |
2.49 |
6,000 |
14,940 |
651,460 |
| Taylor Andrew Lawrence | Chief Financial Officer |
Aug 25 '25 |
Buy |
2.55 |
2,000 |
5,100 |
482,788 |
| PERCEPTIVE ADVISORS LLC | 10% Owner |
Aug 01 '25 |
Buy |
2.75 |
700,000 |
1,925,000 |
5,292,556 |
| Hochman David P | See Remarks |
Aug 04 '25 |
Buy |
2.75 |
20,000 |
55,000 |
349,331 |
| Fain Eric S | Director |
Jun 26 '25 |
Sale |
3.05 |
2,683 |
8,183 |
50,949 |
0.81%
0.77%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):